A citation-based method for searching scientific literature

Samuel A Wells, Bruce G Robinson, Robert F Gagel, Henning Dralle, James A Fagin, Massimo Santoro, Eric Baudin, Rossella Elisei, Barbara Jarzab, James R Vasselli, Jessica Read, Peter Langmuir, Anderson J Ryan, Martin J Schlumberger. J Clin Oncol 2012
Times Cited: 839



Lori J Wirth, Eric Sherman, Bruce Robinson, Benjamin Solomon, Hyunseok Kang, Jochen Lorch, Francis Worden, Marcia Brose, Jyoti Patel, Sophie Leboulleux, Yann Godbert, Fabrice Barlesi, John C Morris, Taofeek K Owonikoko, Daniel S W Tan, Oliver Gautschi, Jared Weiss, Christelle de la Fouchardière, Mark E Burkard, Janessa Laskin, Matthew H Taylor, Matthias Kroiss, Jacques Medioni, Jonathan W Goldman, Todd M Bauer, Benjamin Levy, Viola W Zhu, Nehal Lakhani, Victor Moreno, Kevin Ebata, Michele Nguyen, Dana Heirich, Edward Y Zhu, Xin Huang, Luxi Yang, Jennifer Kherani, S Michael Rothenberg, Alexander Drilon, Vivek Subbiah, Manisha H Shah, Maria E Cabanillas. N Engl J Med 2020
Times Cited: 159




List of shared articles



Times cited

Patient-Reported Outcomes with Selpercatinib Treatment Among Patients with RET-Mutant Medullary Thyroid Cancer in the Phase I/II LIBRETTO-001 Trial.
Lori J Wirth, Bruce Robinson, Valentina Boni, Daniel S W Tan, Caroline McCoach, Erminia Massarelli, Lisa M Hess, Min-Hua Jen, Jennifer Kherani, Elizabeth Olek,[...]. Oncologist 2022
2

State of the art and future directions in the systemic treatment of medullary thyroid cancer.
Eline C Jager, K Esther Broekman, Schelto Kruijff, Thera P Links. Curr Opin Oncol 2022
1

Updates on therapy for medullary thyroid cancer in 2021.
Marie Puerto, Françoise Borson-Chazot, Antoine Tabarin. Ann Endocrinol (Paris) 2022
1

Clinical Application of Next-Generation Sequencing in Advanced Thyroid Cancers.
Lucy X Ma, Osvaldo Espin-Garcia, Philippe L Bedard, Tracy Stockley, Rebecca Prince, Ozgur Mete, Monika K Krzyzanowska. Thyroid 2022
0

Medullary thyroid cancer - An update.
Laura Fugazzola. Best Pract Res Clin Endocrinol Metab 2022
0

An Audit of Systemic Therapy in Medullary Carcinoma Thyroid.
Aditya Pavan Kumar Kanteti, George Abraham, Vijay M Patil, Nandini Menon, Tanmoy Mandal, Sobin V Jacob, Keshav Garg, Anbarasan Sekar, Rup Jyoti Sarma, Laxma Reddy Mekala,[...]. Indian J Surg Oncol 2022
0

Practical lessons from treating medullary thyroid carcinoma patients harboring a RET-alteration: Pralsetinib-induced acute confusional state.
Eliya Shachar, Shira Peleg Hasson, Deborah T Blumenthal, Meerav Fraenkel, Yoel Uri, Ido Wolf, Simona Grozinsky-Glasberg. Acta Oncol 2022
0


Novel Therapeutics and Treatment Strategies for Medullary Thyroid Cancer.
Evan Walgama, Naifa Busaidy, Mark Zafereo. Endocrinol Metab Clin North Am 2022
0

Targeted therapy and drug resistance in thyroid cancer.
Yujie Zhang, Zhichao Xing, Tianyou Liu, Minghai Tang, Li Mi, Jingqiang Zhu, Wenshuang Wu, Tao Wei. Eur J Med Chem 2022
0


Multiple endocrine neoplasia type 2: A review.
Jes Sloth Mathiesen, Grigoris Effraimidis, Maria Rossing, Åse Krogh Rasmussen, Lise Hoejberg, Lars Bastholt, Christian Godballe, Peter Oturai, Ulla Feldt-Rasmussen. Semin Cancer Biol 2022
5

A contemporary review of rearranged during transfection-selective inhibitors.
Angel W Liu, Connie Liang, Chung-Shien Lee. J Oncol Pharm Pract 2022
1

Outcomes of Advanced Medullary Thyroid Carcinoma in the Era of Targeted Therapy.
Nicholas L Kesby, Alexander J Papachristos, Matti Gild, Ahmad Aniss, Mark S Sywak, Roderick Clifton-Bligh, Stan B Sidhu, Anthony R Glover. Ann Surg Oncol 2022
2

The budget impact of adding pralsetinib to a US health plan formulary for treatment of non-small cell lung cancer and thyroid cancer with RET alterations.
Steve Duff, Francesca Bargiacchi, Chelsea Norregaard, Melanie Brener, Erin Sullivan. J Manag Care Spec Pharm 2022
0

Real-world insights into the efficacy and safety of tyrosine kinase inhibitors against thyroid cancers.
Lingyu Li, Lin Cheng, Ri Sa, Xian Qiu, Libo Chen. Crit Rev Oncol Hematol 2022
1

Analogs of the Heat Shock Protein 70 Inhibitor MKT-077 Suppress Medullary Thyroid Carcinoma Cells.
Seung-Keun Hong, Dmytro Starenki, Oleta T Johnson, Jason E Gestwicki, Jong-In Park. Int J Mol Sci 2022
1

Multiple endocrine neoplasia 2: an overview.
B Saravana-Bawan, J D Pasternak. Ther Adv Chronic Dis 2022
0

Resistance to RET targeted therapy in Thyroid Cancer: Molecular basis and overcoming strategies.
María San Román-Gil, Javier Pozas, Diana Rosero-Rodríguez, Jesús Chamorro-Pérez, Álvaro Ruiz-Granados, Ignacio Ruz Caracuel, Enrique Grande, Javier Molina-Cerrillo, Teresa Alonso-Gordoa. Cancer Treat Rev 2022
0

American Head and Neck Society Endocrine Surgery Section and International Thyroid Oncology Group consensus statement on mutational testing in thyroid cancer: Defining advanced thyroid cancer and its targeted treatment.
David C Shonka, Alan Ho, Ashish V Chintakuntlawar, Jessica L Geiger, Jong C Park, Nagashree Seetharamu, Sina Jasim, Amr H Abdelhamid Ahmed, Keith C Bible, Marcia S Brose,[...]. Head Neck 2022
1

Nutrition in Advanced Thyroid Cancer Patients.
Laura Agate, Elisa Minaldi, Alessio Basolo, Valentina Angeli, Roberta Jaccheri, Ferruccio Santini, Rossella Elisei. Nutrients 2022
0

Sporadic Medullary Thyroid Carcinoma: Towards a Precision Medicine.
Antonio Matrone, Carla Gambale, Alessandro Prete, Rossella Elisei. Front Endocrinol (Lausanne) 2022
1

ESMO Clinical Practice Guideline update on the use of systemic therapy in advanced thyroid cancer.
S Filetti, C Durante, D M Hartl, S Leboulleux, L D Locati, K Newbold, M G Papotti, A Berruti. Ann Oncol 2022
0

The Role of the Kinase Inhibitors in Thyroid Cancers.
Francesca Cuomo, Claudio Giani, Gilda Cobellis. Pharmaceutics 2022
0

Thyroid Dysfunction from Treatments for Solid Organ Cancers.
Anupam Kotwal, Donald S A McLeod. Endocrinol Metab Clin North Am 2022
0

FDA Approval Summary: Selpercatinib for the Treatment of Lung and Thyroid Cancers with RET Gene Mutations or Fusions.
Diana Bradford, Erin Larkins, Sirisha L Mushti, Lisa Rodriguez, Amy M Skinner, Whitney S Helms, Lauren S L Price, Jeanne Fourie Zirkelbach, Yangbing Li, Jiang Liu,[...]. Clin Cancer Res 2021
20


Molecular-Driven Therapy in Advanced Thyroid Cancer.
Kevin C Miller, Ashish V Chintakuntlawar. Curr Treat Options Oncol 2021
1

Thyroid cancer and COVID-19: experience at one single thyroid disease referral center.
Alessandro Prete, Marco Falcone, Valeria Bottici, Carlotta Giani, Giusy Tiseo, Laura Agate, Antonio Matrone, Virginia Cappagli, Laura Valerio, Loredana Lorusso,[...]. Endocrine 2021
6

Progress in Treating Advanced Thyroid Cancers in the Era of Targeted Therapy.
Carrie C Lubitz, Peter M Sadow, Gilbert H Daniels, Lori J Wirth. Thyroid 2021
5

Intraductal carcinoma of the salivary gland with NCOA4-RET: expanding the morphologic spectrum and an algorithmic diagnostic approach.
Adam S Fisch, Israa Laklouk, Masato Nakaguro, Vânia Nosé, Lori J Wirth, Daniel G Deschler, William C Faquin, Dora Dias-Santagata, Peter M Sadow. Hum Pathol 2021
2

Current Guidelines for Management of Medullary Thyroid Carcinoma.
Mijin Kim, Bo Hyun Kim. Endocrinol Metab (Seoul) 2021
2


Targeted activity of the small molecule kinase inhibitor Pz-1 towards RET and TRK kinases.
Marialuisa Moccia, Donglin Yang, Naga Rajiv Lakkaniga, Brendan Frett, Nicholas McConnell, Lingtian Zhang, Annalisa Brescia, Giorgia Federico, Lingzhi Zhang, Paolo Salerno,[...]. Sci Rep 2021
0

Metastatic Medullary Thyroid Cancer: The Role of 68Gallium-DOTA-Somatostatin Analogue PET/CT and Peptide Receptor Radionuclide Therapy.
Aimee R Hayes, Alexander Crawford, Khulood Al Riyami, Christine Tang, Jamshed Bomanji, Stephanie E Baldeweg, Damian Wild, Daniel Morganstein, Alice Harry, Simona Grozinsky-Glasberg,[...]. J Clin Endocrinol Metab 2021
4

Precision therapy for RET-altered cancers with RET inhibitors.
Kyaw Z Thein, Vamsidhar Velcheti, Blaine H M Mooers, Jie Wu, Vivek Subbiah. Trends Cancer 2021
8

[Molecular genotyping in refractory thyroid cancers in 2021: When, how and why? A review from the TUTHYREF network].
Christelle de la Fouchardière, Johanna Wassermann, Fabien Calcagno, Stéphane Bardet, Abir Al Ghuzlan, Isabelle Borget, Françoise Borson Chazot, Christine Do Cao, Camille Buffet, Slimane Zerdoud,[...]. Bull Cancer 2021
0

Continued Discontinuation of TKI Treatment in Medullary Thyroid Carcinoma - Lessons From Individual Cases With Long-Term Follow-Up.
Tim Brandenburg, Vera Tiedje, Philipp Muchalla, Sarah Theurer, Frank Weber, Kurt Werner Schmid, Henning Dralle, Dagmar Führer. Front Endocrinol (Lausanne) 2021
0


Management of VEGFR-Targeted TKI for Thyroid Cancer.
Tomohiro Enokida, Makoto Tahara. Cancers (Basel) 2021
0